Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Changing concepts in multiple myeloma: from conventional chemotherapy to high-dose treatmentP Sonneveld, C M Segeren
The Netherlands Journal of Medicine|January 1, 1997
Agenesis of the corpus callosum associated with paroxysmal hypothermia: Shapiro's syndromeC M Segeren, K H Polderman, P Lips
Nederlands Tijdschrift Voor Geneeskunde|October 9, 1998
[Multiple myeloma; treatment in the year 1998]H M Lokhorst, P Sonneveld, P W Wijermans, et al.
Annals of Hematology|June 1, 1995
AML-MO: clinical entity or waste basket for immature blastic leukemias? A description of 14 patients. Dutch Slide Review Committee of Leukemias in AdultsC M Segeren, G C de Jong-Gerrits, M B van 't Veer
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|October 14, 2000
Endovascular repair of an extracranial internal carotid artery aneurysm complicated by heparin-induced thrombocytopenia and thrombosisM R van Sambeek, C M Segeren, L C van Dijk, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma; a prospective randomised phase III studyM van Agthoven, C M Segeren, I Buijt, et al.
Cancer Research|May 19, 2001
Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cellsP de Lange, C M Segeren, J W Koper, et al.
British Journal of Haematology|February 15, 2002
Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)P Sonneveld, S Suciu, P Weijermans, et al.
British Journal of Haematology|May 8, 1999
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myelomaC M Segeren, P Sonneveld, B van der Holt, et al.
Pageof 1